Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
The global market for Albendazole was estimated to be worth US$ 159.1 million in 2023 and is forecast to a readjusted size of US$ 270.8 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Albendazole, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Albendazole by region & country, by Type, and by Application.
The Albendazole market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole.
Market Segmentation
By Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segment by Type:
Tablet
Capsule
Other
Segment by Application
Human
Veterinary
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Albendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Albendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Albendazole in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Albendazole Product Introduction
1.2 Global Albendazole Market Size Forecast
1.2.1 Global Albendazole Sales Value (2019-2030)
1.2.2 Global Albendazole Sales Volume (2019-2030)
1.2.3 Global Albendazole Sales Price (2019-2030)
1.3 Albendazole Market Trends & Drivers
1.3.1 Albendazole Industry Trends
1.3.2 Albendazole Market Drivers & Opportunity
1.3.3 Albendazole Market Challenges
1.3.4 Albendazole Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Albendazole Players Revenue Ranking (2023)
2.2 Global Albendazole Revenue by Company (2019-2024)
2.3 Global Albendazole Players Sales Volume Ranking (2023)
2.4 Global Albendazole Sales Volume by Company Players (2019-2024)
2.5 Global Albendazole Average Price by Company (2019-2024)
2.6 Key Manufacturers Albendazole Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Albendazole Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Albendazole
2.9 Albendazole Market Competitive Analysis
2.9.1 Albendazole Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Albendazole Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Capsule
3.1.3 Other
3.2 Global Albendazole Sales Value by Type
3.2.1 Global Albendazole Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Albendazole Sales Value, by Type (2019-2030)
3.2.3 Global Albendazole Sales Value, by Type (%) (2019-2030)
3.3 Global Albendazole Sales Volume by Type
3.3.1 Global Albendazole Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Albendazole Sales Volume, by Type (2019-2030)
3.3.3 Global Albendazole Sales Volume, by Type (%) (2019-2030)
3.4 Global Albendazole Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human
4.1.2 Veterinary
4.2 Global Albendazole Sales Value by Application
4.2.1 Global Albendazole Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Albendazole Sales Value, by Application (2019-2030)
4.2.3 Global Albendazole Sales Value, by Application (%) (2019-2030)
4.3 Global Albendazole Sales Volume by Application
4.3.1 Global Albendazole Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Albendazole Sales Volume, by Application (2019-2030)
4.3.3 Global Albendazole Sales Volume, by Application (%) (2019-2030)
4.4 Global Albendazole Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Albendazole Sales Value by Region
5.1.1 Global Albendazole Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Albendazole Sales Value by Region (2019-2024)
5.1.3 Global Albendazole Sales Value by Region (2025-2030)
5.1.4 Global Albendazole Sales Value by Region (%), (2019-2030)
5.2 Global Albendazole Sales Volume by Region
5.2.1 Global Albendazole Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Albendazole Sales Volume by Region (2019-2024)
5.2.3 Global Albendazole Sales Volume by Region (2025-2030)
5.2.4 Global Albendazole Sales Volume by Region (%), (2019-2030)
5.3 Global Albendazole Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Albendazole Sales Value, 2019-2030
5.4.2 North America Albendazole Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Albendazole Sales Value, 2019-2030
5.5.2 Europe Albendazole Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Albendazole Sales Value, 2019-2030
5.6.2 Asia Pacific Albendazole Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Albendazole Sales Value, 2019-2030
5.7.2 South America Albendazole Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Albendazole Sales Value, 2019-2030
5.8.2 Middle East & Africa Albendazole Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Albendazole Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Albendazole Sales Value
6.2.1 Key Countries/Regions Albendazole Sales Value, 2019-2030
6.2.2 Key Countries/Regions Albendazole Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Albendazole Sales Value, 2019-2030
6.3.2 United States Albendazole Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Albendazole Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Albendazole Sales Value, 2019-2030
6.4.2 Europe Albendazole Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Albendazole Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Albendazole Sales Value, 2019-2030
6.5.2 China Albendazole Sales Value by Type (%), 2023 VS 2030
6.5.3 China Albendazole Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Albendazole Sales Value, 2019-2030
6.6.2 Japan Albendazole Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Albendazole Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Albendazole Sales Value, 2019-2030
6.7.2 South Korea Albendazole Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Albendazole Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Albendazole Sales Value, 2019-2030
6.8.2 Southeast Asia Albendazole Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Albendazole Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Albendazole Sales Value, 2019-2030
6.9.2 India Albendazole Sales Value by Type (%), 2023 VS 2030
6.9.3 India Albendazole Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Information
7.1.2 GlaxoSmithKline Introduction and Business Overview
7.1.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GlaxoSmithKline Albendazole Product Offerings
7.1.5 GlaxoSmithKline Recent Development
7.2 Huazhong Pharmaceutical
7.2.1 Huazhong Pharmaceutical Company Information
7.2.2 Huazhong Pharmaceutical Introduction and Business Overview
7.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Huazhong Pharmaceutical Albendazole Product Offerings
7.2.5 Huazhong Pharmaceutical Recent Development
7.3 Jiangsu Qihui
7.3.1 Jiangsu Qihui Company Information
7.3.2 Jiangsu Qihui Introduction and Business Overview
7.3.3 Jiangsu Qihui Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Jiangsu Qihui Albendazole Product Offerings
7.3.5 Jiangsu Qihui Recent Development
7.4 Sequent Scientific
7.4.1 Sequent Scientific Company Information
7.4.2 Sequent Scientific Introduction and Business Overview
7.4.3 Sequent Scientific Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sequent Scientific Albendazole Product Offerings
7.4.5 Sequent Scientific Recent Development
7.5 K.A. Malle Pharmaceuticals
7.5.1 K.A. Malle Pharmaceuticals Company Information
7.5.2 K.A. Malle Pharmaceuticals Introduction and Business Overview
7.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.5.4 K.A. Malle Pharmaceuticals Albendazole Product Offerings
7.5.5 K.A. Malle Pharmaceuticals Recent Development
7.6 Lasa Supergenerics Limited
7.6.1 Lasa Supergenerics Limited Company Information
7.6.2 Lasa Supergenerics Limited Introduction and Business Overview
7.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lasa Supergenerics Limited Albendazole Product Offerings
7.6.5 Lasa Supergenerics Limited Recent Development
7.7 Zhongjia Pharmaceutical
7.7.1 Zhongjia Pharmaceutical Company Information
7.7.2 Zhongjia Pharmaceutical Introduction and Business Overview
7.7.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Zhongjia Pharmaceutical Albendazole Product Offerings
7.7.5 Zhongjia Pharmaceutical Recent Development
7.8 Fredun Pharmaceuticals Ltd
7.8.1 Fredun Pharmaceuticals Ltd Company Information
7.8.2 Fredun Pharmaceuticals Ltd Introduction and Business Overview
7.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Offerings
7.8.5 Fredun Pharmaceuticals Ltd Recent Development
7.9 Supharma Chem
7.9.1 Supharma Chem Company Information
7.9.2 Supharma Chem Introduction and Business Overview
7.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Supharma Chem Albendazole Product Offerings
7.9.5 Supharma Chem Recent Development
7.10 Salius Pharma
7.10.1 Salius Pharma Company Information
7.10.2 Salius Pharma Introduction and Business Overview
7.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Salius Pharma Albendazole Product Offerings
7.10.5 Salius Pharma Recent Development
8 Industry Chain Analysis
8.1 Albendazole Industrial Chain
8.2 Albendazole Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Albendazole Sales Model
8.5.2 Sales Channel
8.5.3 Albendazole Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
*If Applicable.